- Home
- MDXG vs IRS Comparison
MDXG vs IRS Comparison
Compare MDXG & IRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- IRS
- Stock Information
- Founded
- MDXG 2006
- IRS 1943
- Country
- MDXG United States
- IRS Argentina
- Employees
- MDXG N/A
- IRS N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- IRS Homebuilding
- Sector
- MDXG Health Care
- IRS Real Estate
- Exchange
- MDXG Nasdaq
- IRS Nasdaq
- Market Cap
- MDXG 1.0B
- IRS 959.8M
- IPO Year
- MDXG N/A
- IRS 1994
- Fundamental
- Price
- MDXG $7.27
- IRS $11.36
- Analyst Decision
- MDXG Buy
- IRS
- Analyst Count
- MDXG 1
- IRS 0
- Target Price
- MDXG $12.00
- IRS N/A
- AVG Volume (30 Days)
- MDXG 650.1K
- IRS 301.2K
- Earning Date
- MDXG 10-29-2025
- IRS 11-05-2025
- Dividend Yield
- MDXG N/A
- IRS 8.73%
- EPS Growth
- MDXG N/A
- IRS N/A
- EPS
- MDXG 0.21
- IRS 0.20
- Revenue
- MDXG $363,774,000.00
- IRS $416,589,564.00
- Revenue This Year
- MDXG $12.68
- IRS N/A
- Revenue Next Year
- MDXG $8.18
- IRS N/A
- P/E Ratio
- MDXG $34.82
- IRS $5.67
- Revenue Growth
- MDXG 6.85
- IRS N/A
- 52 Week Low
- MDXG $5.47
- IRS $10.61
- 52 Week High
- MDXG $10.14
- IRS $17.67
- Technical
- Relative Strength Index (RSI)
- MDXG 56.76
- IRS 35.10
- Support Level
- MDXG $6.62
- IRS $11.25
- Resistance Level
- MDXG $7.04
- IRS $11.91
- Average True Range (ATR)
- MDXG 0.23
- IRS 0.63
- MACD
- MDXG 0.02
- IRS -0.03
- Stochastic Oscillator
- MDXG 86.52
- IRS 5.41
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About IRS IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segment includes Shopping Malls; Offices; Sales and Developments; Hotels and others. It generates maximum revenue from the Shopping Malls segment. The Shopping Malls segment comprised of lease and service revenues related to rental of commercial space and other spaces in the shopping malls of the company.